Local anesthetic dosing and toxicity of pediatric truncal catheters: a narrative review of published practice
Regional Anesthesia & Pain Medicine · 2024
DOI: 10.1136/rapm-2023-104666 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regional Anesthesia & Pain Medicine, 2024. Verfasst von Michael Fettiplace und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA fettiplace@gmail.com. Hauptthemen laut MEDLINE: Anesthetics, Local, Nerve Block. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIH.
Abstract (Originalsprache)
Background/importance Despite over 30 years of use by pediatric anesthesiologists, standardized dosing rates, dosing characteristics, and cases of toxicity of truncal nerve catheters are poorly described.
Objective
We reviewed the literature to characterize dosing and toxicity of paravertebral and transversus abdominis plane catheters in children (less than 18 years). Evidence review We searched for reports of ropivacaine or bupivacaine infusions in the paravertebral and transversus abdominis space intended for 24 hours or more of use in pediatric patients. We evaluated bolus dosing, infusion dosing, and cumulative 24-hour dosing in patients over and under 6 months. We also identified cases of local anesthetic systemic toxicity and toxic blood levels.
Findings
Following screening, we extracted data from 46 papers with 945 patients. Bolus dosing was 2.5 mg/kg (median, range 0.6–5.0; n=466) and 1.25 mg/kg (median, range 0.5–2.5; n=294) for ropivacaine and bupivacaine, respectively. Infusion dosing was 0.5 mg/kg/hour (median, range 0.2–0.68; n=521) and 0.33 mg/kg/hour (median, range 0.1–1.0; n=423) for ropivacaine and bupivacaine, respectively, consistent with a dose equivalence of 1.5:1.0. A single case of toxicity was reported, and pharmacokinetic studies reported at least five cases with serum levels above the toxic threshold.
Conclusions
Bolus doses of bupivacaine and ropivacaine frequently comport with expert recommendations. Infusions in patients under 6 months used doses associated with toxicity and toxicity occurred at a rate consistent with single-shot blocks. Pediatric patients would benefit from specific recommendations about ropivacaine and bupivacaine dosing, including age-based dosing, breakthrough dosing, and intermittent bolus dosing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA fettiplace@gmail.com.
- Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Anesthesiology, Critical Care and Pain Medicine, Boston Childrens Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Michael Fettiplace, Brittani Bungart, Karen Boretsky
Förderung
- NIGMS NIH HHS
- NIH
Zitieren
APA
Fettiplace, M., Joudeh, L., Bungart, B., & Boretsky, K. (2024). Local anesthetic dosing and toxicity of pediatric truncal catheters: a narrative review of published practice. Regional Anesthesia & Pain Medicine. https://doi.org/10.1136/rapm-2023-104666
Vancouver
Fettiplace M, Joudeh L, Bungart B, Boretsky K. Local anesthetic dosing and toxicity of pediatric truncal catheters: a narrative review of published practice. Regional Anesthesia & Pain Medicine. 2024. doi:10.1136/rapm-2023-104666
BibTeX
@article{Fettiplace2024,
author = {Fettiplace, Michael and Joudeh, Lana and Bungart, Brittani and Boretsky, Karen},
title = {Local anesthetic dosing and toxicity of pediatric truncal catheters: a narrative review of published practice},
journal = {Regional Anesthesia & Pain Medicine},
year = {2024},
doi = {10.1136/rapm-2023-104666}
}
EUVIMED